10-103584676-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004210.5(NEURL1):āc.790G>Cā(p.Glu264Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000357 in 1,428,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004210.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEURL1 | NM_004210.5 | c.790G>C | p.Glu264Gln | missense_variant | 4/6 | ENST00000369780.9 | NP_004201.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEURL1 | ENST00000369780.9 | c.790G>C | p.Glu264Gln | missense_variant | 4/6 | 1 | NM_004210.5 | ENSP00000358795 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000231 AC: 35AN: 151506Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000512 AC: 4AN: 78146Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 46922
GnomAD4 exome AF: 0.0000125 AC: 16AN: 1277254Hom.: 0 Cov.: 31 AF XY: 0.00000476 AC XY: 3AN XY: 630138
GnomAD4 genome AF: 0.000231 AC: 35AN: 151614Hom.: 0 Cov.: 31 AF XY: 0.000202 AC XY: 15AN XY: 74146
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The c.790G>C (p.E264Q) alteration is located in exon 4 (coding exon 4) of the NEURL1 gene. This alteration results from a G to C substitution at nucleotide position 790, causing the glutamic acid (E) at amino acid position 264 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at